GLENMARK.NS Forward P/E

The Forward P/E of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 28.39.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

GLENMARK.NS Forward P/E - Peers Comparison

Ticker	Name	Value
IPCALAB.NS	IPCA Laboratories Ltd	39.31
SUVENPHAR.NS	Suven Pharmaceuticals Ltd	73.37
AJANTPHARM.NS	Ajanta Pharma Ltd	35.27
GRANULES.NS	Granules India Ltd	25.15
PFIZER.NS	Pfizer Ltd	33.54
JBCHEPHARM.NS	J B Chemicals and Pharmaceuticals Ltd	38.41
ALKEM.NS	Alkem Laboratories Ltd	28.36
LAURUSLABS.NS	Laurus Labs Ltd	57.34
MARKSANS.NS	Marksans Pharma Ltd	29.65
TORNTPHARM.NS	Torrent Pharmaceuticals Ltd	56.69
ABBOTINDIA.NS	Abbott India Ltd	45.38
GLAXO.NS	GlaxoSmithKline Pharmaceuticals Ltd	52.65
AARTIDRUGS.NS	Aarti Drugs Ltd	12.15
SOLARA.NS	Solara Active Pharma Sciences Ltd	26.46
STAR.NS	Strides Pharma Science Ltd	16.46
SANOFI.NS	Sanofi India Ltd	35.11
APLLTD.NS	Alembic Pharmaceuticals Ltd	26.77
ERIS.NS	Eris Lifesciences Ltd	52.86
NATCOPHARM.NS	Natco Pharma Ltd	7.75
HIKAL.NS	Hikal Ltd	68.42
IOLCP.NS	IOL Chemicals and Pharmaceuticals Ltd	17.13